Company Overview of Omthera Pharmaceuticals, Inc.
Key Executives for Omthera Pharmaceuticals, Inc.
|Stephen F. Mohr||6 Relationships||Chairman and President||--|
|Michael H. Davidson M.D., Facc., Facp.||91 Relationships||Co-Founder and Chief Medical Officer||59|
|Mark S. Uhle||No Relationships||Chief Financial Officer and Vice President of Finance||--|
|Douglas Carr||No Relationships||Financial Controller||--|
|Bharat M. Mehta Ph.D.||No Relationships||Vice President of CMC/Manufacturing||--|
Omthera Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Stephen F. Mohr||6 Relationships||Omthera Pharmaceuticals, Inc.||--|
|Daniel J. Rader M.D., FAHA||50 Relationships||Vascular Strategies LLC||--|
|Johannes Jacob Pieter Kastelein M.D., Ph.D., FESC||107 Relationships||AtheroNova Inc.||62|
|David G. Orloff M.D.||37 Relationships||Diasome Pharmaceuticals, Inc.||--|
|Kevin C. Maki Ph.D.||28 Relationships||Matinas BioPharma Holdings, Inc.||--|
Omthera Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D., FAHA||Daniel J. Rader||50 Relationships||4 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.